cisatracurium

(redirected from Cisatracurium besylate)

cisatracurium

[sis″at-rah-kūr´e-um]

a nondepolarizing neuromuscular blocking agent administered intravenously as the besylate salt administered intravenously to facilitate endotracheal intubation and to induce skeletal muscle relaxation, either as an adjunct to general anesthesia during surgery or during mechanical ventilation.

cisatracurium

/cis·at·ra·cu·ri·um/ (sis″at-rah-kūr´e-um) a nondepolarizing neuromuscular blocking agent administered intravenously as the besylate salt as an adjunct to general anesthesia or during mechanical ventilation.

cisatracurium

a nondepolarizing neuromuscular blocker.

indications It is used to facilitate endotracheal intubation and skeletal muscle relaxation during mechanical ventilation, surgery, or general anesthesia.

contraindications Known hypersensitivity to this drug prohibits its use.

adverse effects Life-threatening effects include prolonged apnea, bronchospasm, cyanosis, and respiratory depression. Other serious adverse effects include bradycardia, tachycardia, and increased/decreased blood pressure.

cisatracurium

Anesthesiology A stereoisomer of atracurium, a nondepolarizing muscle relaxing anesthetic preferred in multiorgan failure. See Muscle relaxant, Nondepolarizing agent. Cf Depolarizing agent.

References in periodicals archive ?

Nebraska is currently planning to execute inmates with a never-before-tried mix of four drugs: diazepam (more commonly known as Valium), potassium chloride, cisatracurium besylate (a paralytic), and fentanyl citrate.

AMERICA'S SECRET DEATH PENALTY DRUGS

Fresenius Kabi, a Germany-based health care company, has introduced its Cisatracurium Besylate Injection, a new specialty injectable product, in three presentations in the United States, it was reported yesterday.

Cisatracurium Besylate Injection launched in US by Fresenius Kabi

In the neurological population it is most often used for patients placed on a neuromuscular blockade drip such as cisatracurium besylate (Nimbex), which is accompanied by sedation such as propofol (Diprivan), and for patients placed in a pentobarbital-induced coma.

Bispectral index monitoring in the neurointensive care unit

Frederic Chopin in Rzeszow, and including - Part 1 - cisatracurium besylate 10 mg / 5 ml and 5 mg / 2.